人乳头瘤病毒相关口咽癌的颈部淋巴结转移模式
结果显示转移主要位于II区(75.6%),其次为III区(22.0%),I区无转移;选择性颈清扫中23.8%存在隐匿转移,均位于II区且无结外扩展。结论建议治疗性颈清扫应涵盖IIA-B、III、IV区,选择性颈清扫至少涵盖IIA-B和III区。
要点
- p16+OPSCC淋巴结转移最常见于II区(75.6%),III区为22.0%,I区无转移。
- 选择性颈清扫中23.8%存在隐匿转移,均位于II区且无结外扩展。
- 治疗性颈清扫应涵盖IIA-B、III、IV区,选择性颈清扫至少涵盖IIA-B和III区。
核心结论
- p16+OPSCC治疗性颈清扫应涵盖任何含可疑淋巴结的分区及IIA-B、III、IV区,选择性颈清扫应涵盖至少IIA-B和III区。
主要发现
- 转移病理淋巴结频率:I区0%(0/28),II区75.6%(62/82),其中IIA区57.4%(35/61)、IIB区13.1%(8/61),III区22.0%(18/82),IV区7.0%(5/71),V区6.3%(1/16)。
- 21例选择性颈清扫中5例(23.8%)含隐匿淋巴结,均位于II区且无结外扩展。
- 平均随访29个月,3例出现复发,除1例外其余患者仍存活;所有复发患者均拒绝至少部分辅助治疗。
关键数值与推荐
- 治疗性颈清扫应涵盖含可疑淋巴结的分区及IIA-B、III、IV区。
- 选择性颈清扫应涵盖至少IIA-B和III区。
临床怎么用
- 对p16+OPSCC患者行颈清扫时,应按上述分区范围设计手术,术后辅以指征明确的辅助治疗,以实现低淋巴结复发率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize patterns of neck lymph node (LN) metastases in human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma, represented by p16 positivity (p16+OPSCC). STUDY DESIGN: Case series with chart review. SETTING: Tertiary care center. SUBJECTS AND METHODS: Neck dissection (ND) specimens of nonirradiated p16+OPSCC patients were analyzed for frequencies of clinically evident and occult LNs by neck level. Local, regional, and distant recurrences were reviewed. RESULTS: Seventy p16+OPSCC patients underwent primary site transoral robotic surgery and 82 NDs of varying levels. Metastatic pathologic LNs were found at the following frequencies: 0% (0/28) in level I, 75.6% (62/82) in level II with 57.4% (35/61) in level IIA and 13.1% (8/61) in level IIB, 22.0% (18/82) in level III, 7.0% (5/71) in level IV, and 6.3% (1/16) in level V. The level V LN was clinically evident preoperatively. Five of 21 (23.8%) elective NDs contained occult LNs, all of which were in level II and without extranodal extension. Twenty-seven (38.6%) patients underwent adjuvant radiation; 19 (27.1%) patients underwent adjuvant chemoradiation. With a mean follow-up of 29 months, 3 patients had developed recurrences, with all but 1 patient still alive. All patients who recurred had refused at least a component of indicated adjuvant treatment. CONCLUSIONS: For p16+OPSCC, therapeutic NDs should encompass any levels bearing suspicious LNs and levels IIA-B, III, and IV, while elective NDs should be performed and encompass at least levels IIA-B and III. These selective ND plans, followed by indicated adjuvant treatment, are associated with a low nodal recurrence rate.
引用
- Plonowska KA, Strohl MP, Wang SJ, et al. Human Papillomavirus-Associated Oropharyngeal Cancer: Patterns of Nodal Disease. Otolaryngol Head Neck Surg. 2018. PMID: 30274544. doi:10.1177/0194599818801907
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。